AQSP.jpg
Lifted Made, a Subsidiary of Acquired Sales Corp. (OTCQX: AQSP), Signs an Agreement With Nepa Wholesale Inc. for Exclusive Distribution in Florida of New Urb Finest Flowers Brand Custom Disposable Devices Containing Hemp-Derived Cannabinoids That Could Generate Up to $19,656,000 in Gross Revenue Over a Three Year Period
June 21, 2021 07:00 ET | Acquired Sales Corp.
JACKSONVILLE, Fla., June 21, 2021 (GLOBE NEWSWIRE) -- Acquired Sales Corp. (OTCQX: AQSP) today announced that its wholly owned subsidiary Lifted Made, Kenosha, Wisconsin (www.LiftedMade.com) has...
Black-Enochian-Primary-Logo.jpg
Enochian BioSciences Announces Acquisition of Exclusive License for Potential Pan-Coronavirus and Pan-Influenza Inhaled Treatment and Prevention Technology
June 21, 2021 07:00 ET | Enochian BioSciences, Inc.
LOS ANGELES, June 21, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today...
Fulcrum-Logo_Primary_Full-Color_RGB_Large copy.jpg
Fulcrum Therapeutics Announces Multiple Presentations at the 28th Annual FSHD Society International Research Congress (IRC)
June 21, 2021 07:00 ET | Fulcrum Therapeutics
CAMBRIDGE, Mass., June 21, 2021 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with...
medipharm logo.jpg
MediPharm Labs Enters Research Agreement with McMaster University to Develop Drugs Containing Cannabis Candidates
June 21, 2021 07:00 ET | MediPharm Labs Corp.
MediPharm Labs’ Cannabis Drug Licence and expertise qualifies and positions the Company to supply clinical trial material, assist in investigation protocol and provide regulatory support for multiple...
DayOneBio_Logo_RGB_Square_large.jpg
Day One Receives Orphan Designation from the European Commission for DAY101 for the Treatment of Glioma
June 21, 2021 07:00 ET | Day One Biopharmaceuticals, Inc.
SOUTH SAN FRANCISCO, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies...
Oyster_Point_Social.jpg
Oyster Point Pharma Announces Enrollment of First Subject in the OLYMPIA Phase 2 Clinical Trial of OC-01 (varenicline) Nasal Spray for Patients with Neurotrophic Keratopathy
June 21, 2021 07:00 ET | Oyster Point Pharma, Inc.
PRINCETON, N.J., June 21, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of...
Anavex Life Sciences Corp.
Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Biomarker Correlated with Efficacy Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome
June 21, 2021 07:00 ET | Anavex Life Sciences Corp.
ANAVEX®2-73 treatment resulted in significant increase in the expression of the SIGMAR1 mRNA biomarker that significantly correlated with improvements in the two primary clinical efficacy endpoints...
Tonix2.jpg
Tonix Pharmaceuticals Announces Program to Develop TNX-102 SL for the Treatment of Long COVID Syndrome, also Known as Post-Acute Sequelae of COVID-19 (PASC)
June 21, 2021 07:00 ET | Tonix Pharmaceuticals Holding Corp.
Long COVID Symptoms of Pain, Sleep Disturbance, Fatigue and Brain Fog Overlap with Symptoms of Fibromyalgia, for which TNX-102 SL is in Mid-Phase 3 Development Condition Afflicts More Than 30...
rosinbomb.png
ROSINBOMB™ Featured in Exclusive Interview With Blunt Business on Cannabis Radio
June 21, 2021 07:00 ET | Rosinbomb
RENO, Nev., June 21, 2021 (GLOBE NEWSWIRE) -- ROSINBOMB (OTC:ROSN), industry leading developer and manufacturer of the highly acclaimed ROSINBOMB line of solventless extraction presses was the...
akoustis tm.jpg
Akoustis Signs First Foundry Agreement with 5G Mobile RF Front-End Customer
June 21, 2021 07:00 ET | Akoustis, Inc.
Akoustis to Produce Filters for 5G Mobile Smartphones and Other Devices Production Ramp Expected in 2nd Half of Calendar 2022 Charlotte, N.C., June 21, 2021 (GLOBE NEWSWIRE) -- Akoustis...